Is Selinexor available for purchase through hospitals in the country?

Selinexor () is a new, oral, selective nuclear export protein inhibitor primarily used to treat multiple myeloma and certain types of lymphoma. It inhibits the XPO1 protein and prevents the efflux of tumor suppressor factors from the nucleus, thereby inducing tumor cell apoptosis. The drug has a unique mechanism of action and provides a new treatment option for relapsed or refractory patients who have failed multiple treatments.

At present, Seleniso has been officially approved for marketing in my country and has been included in the national medical insurance directory. Patients can purchase the drug through regular domestic hospital pharmacies, which to a certain extent alleviates the situation where patients had to rely on overseas channels to purchase drugs. According to different specifications and manufacturers, the domestic price of Seleniso ranges from about 5,000 yuan to more than 10,000 yuan. Since medical insurance reimbursement policies vary from region to region, it is recommended that patients consult the medical insurance department of their hospital before purchasing drugs to obtain accurate reimbursement ratio and payment amount information.

In addition to domestic original drugs, some patients will also consider overseas generic drugs, especially the Lao version of selinexol. The price of such generic drugs is usually around more than 2,000 yuan, which is much lower than the price of domestic original drugs. Although it is a generic version, its drug ingredients are basically the same as those of the original drug, and some patients have reported that the results are satisfactory. However, if patients need to use overseas drugs, they should ensure that they are purchased through legal and reliable channels to ensure drug safety and efficacy.

In general, the domestic listing of Seleniso and its inclusion in medical insurance provide patients in need with more convenient treatment channels and a certain degree of economic security. For patients with different economic conditions, domestic original drugs and overseas generic drugs can be used as treatment options. The key is to weigh the efficacy, channel safety, and own affordability, and make reasonable decisions after communicating with the attending doctor.

Reference materials:https://www.selincro.com/